Browse studies
Find your next paid study
4 recruiting studies matching your filters
In-Office Transperineal Laser Ablation (TPLA) as a Salvage Treatment for Obstructive Benign Prostatic Hyperplasia (BPH) After Minimally Invasive Surgical Therapies (MIST)
Benign prostatic hyperplasia (BPH) is a common condition affecting aging men, often leading to lower urinary tract symptoms (LUTS). While Minimally Invasive Su…
Benign Prostatic Hyperplasia (BPH)
Estimated
~$10 – $750
The Cleveland ClinicNCT07016620
The FLOW Registry: Functional and Longitudinal Outcomes With Waterjet Ablation
The purpose of this study is to create a database and prospective registry for data collection on patients with benign prostatic hyperplasia undergoing Aquabla…
Benign Prostatic Hyperplasia (BPH)
Estimated
~$10 – $750
University of ChicagoNCT07430423
Observational
A Post-Market, Prospective, Randomized, Controlled, Multicenter International Study to Assess the Safety of the Temporarily Implanted Nitinol Device (iTind) Compared to the UroLift® System in Subjects With Symptomatic Benign Prostatic Hyperplasia (BPH)
The study objective is to evaluate the safety of the iTind device comparied to UroLift.
Benign Prostatic Hyperplasia (BPH)
Estimated
~$10 – $8,750
Olympus Corporation of the AmericasNCT04757116
Phase 2
Effects of TNF Blockade on Human BPH/LUTS
Specific Aim 1. To evaluate the efficacy of TNF antagonist action in BPH/LUTS Specific Aim 2. Define the consequences of TNF antagonist therapy on prostate tis…
Benign Prostatic Hyperplasia (BPH)
Estimated
~$10 – $7,500
Endeavor HealthNCT06062875